GenomesDAO was a project that came up several months ago and I believe it deserves renewed attention for several compelling reasons. Currently valued at just $4.11 million, I believe this project appears to be significantly undervalued.
In a recent tweet when CZ was saying his farewells to Binance and passing on the torch, he made what I would call an eyebrow raising comment within it:
‘’My current thinking is I will probably do some passive investing, being a minority token/shareholder in startups in areas of blockchain/Web3/DeFi, AI + BIOTECH.’’
CZ here explicitly mentions biotech, suggesting a strategic foresight into an upcoming trend, and GenomesDAO in my opinion stands well-positioned to capitalize on this potential.
In August, the project secured a substantial financial commitment of $20 million from GEM Digital aimed at accelerating its technological development . Furthermore, GenomesDAO achieved a noteworthy milestone by becoming the first company to directly compensate its vault holders for scientific research, contributing to the advancement of genomic insights in the same month.
With these promising developments, coupled with CZ's nod towards the potential in biotech, I think it would be prudent not to underestimate the significant undervaluation of GenomesDAO. This project appears poised to make substantial strides in the burgeoning intersection of blockchain, biotech and genomic research. Show Less
3
